NHS Dudley Health Economy Medicines Formulary
Home > 2 Cardiovascular system > 2.9 Antiplatelet drugs > Ticagrelor for preventing atherothrombotic events after myocardial infarction - NICE TAG TA420

Ticagrelor for preventing atherothrombotic events after myocardial infarction - NICE TAG TA420

1.1 Ticagrelor, in combination with aspirin, is recommended within its marketing authorisation as an option for preventing atherothrombotic events in adults who had a myocardial infarction and who are at high risk of a further event.

Treatment should be stopped when clinically indicated or at a maximum of 3 years.

Site by Devopa
© Copyright 2019 NHS. All rights reserved.